Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Vocodia Enters Mass Tort Sector With AI-Driven Intake, Marketing, and Lead Generation Platform
-
IMUNON Announces Pricing of $7.0 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules
-
Safe & Green Holdings Adjourns 2025 Annual Meeting Due to Lack of Quorum; Sets Virtual Reconvening for Jan. 14
-
Snail Inc. Closes the Year with High Engagement Across Core IPs, Signaling Strong Momentum Into 2026
-
La Rosa Holdings Corp. Announces Appointment of Nicholas Adler as Chairman of the Board and Chairman of the Compensation Committee
-
Defiance Launches BTFL: The First Daily 2X Long ETF for Bitfarms Ltd.
-
SRx Health Solutions Deploys Initial $10 Million into Several Digital Assets Predominantly Bitcoin and Ethereum
-
Truth Social ETFs Launch Today
-
Autonomix Medical, Inc. Granted European Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology
-
Pure Cycle Corporation Announces Dates for Q1 2026 Earnings Presentation
-
Form 8.3 - Bluefield Solar Income Fund Ltd
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRE HEALTHCARE GROUP PLC - Ordinary Shares
-
How Real Estate Expert Tad Barber of Aiken, SC, Explains the 2026 Housing Market for HelloNation
-
VivoPower to Add $10 Million Proforma EBITDA from Proposed Acquisition of 40MW+ Energized Norway Data Center Ready for Sovereign AI Pivot
-
SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects
-
Sustainable Innovation & Health Dividend Fund Announces Special Distribution
-
Oxylabs AI Predictions for 2026: Greater Impact with Fewer Breakthroughs
-
Vanguard Announces Final Cash Distributions for the Vanguard ETFs
-
Xeriant Wishes Shareholders a Joyous Holiday Season and Banner 2026
-
Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15
-
Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in NonAdvanced Systemic Mastocytosis
-
Beyond Oil Announces Additional Order from Exclusive Distributor Pilpel Following Accelerated Market Adoption in Central Europe
-
SAGA Metals Completes Annual Work Program at North Wind Iron Ore Project & Provides Corporate Update
-
Maxus Mining Highlights Antimony Results at the Hurley Project in British Columbia, Canada
-
AmpliTech Group Achieves 100% Open RAN Handover Validation at POWDER OTIC PlugFest Featuring AT&T, DISH Wireless, Samsung, VMware, and Other Leading Global Participants
-
Pan American Energy Reports Final Bathymetric Results from Tharsis Project, Northwest Territories
-
Duos Edge AI Expands Within and Beyond Texas
-
Napster Launches Napster Station: The First AI Concierge Built to Provide Personalized Service in Crowded Spaces
-
BLAQclouds Unveils New ApolloCASH User Interface, Streamlining Secure Send and Redeem Transactions
-
Picard Medical CEO Patrick NJ Schnegelsberg Elected to AZBio Board of Directors
-
REV Arranges $5.5 Million in Private Placements with Eric Sprott as Lead Order
-
Tidal Financial Group Announces the Launch of the TimesSquare Quality Mid Cap Growth ETF (TSCM)
-
Aemetis Receives Funds from the Sale of $17 million of Federal Clean Energy Tax Credits
-
Northern Technologies International Corporation to Announce Fiscal 2026 First-Quarter Financial Results and Host Conference Call
-
BullFrog AI Publishes Annual Letter to Shareholders
-
Prenetics Announces Update to Capital Allocation Strategy; Ceases Bitcoin Purchases to Focus on IM8
-
OFA Group Confirms Commercial Launch of QikBIM and RWA Platform in 2026, Establishing Core AI Infrastructure for Global Revenue Growth
-
Nano Labs Announces Results of Annual General Meeting of Shareholders
-
Etoiles Capital Group Co., Ltd. Announces Unaudited Financial Results For The Six Months Ended June 30, 2025
-
Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor
-
The 2025 Brain Health Breakthrough of the Year
-
Safe Harbor Bolsters Lending Capabilities and Client Experience with Strategic Leadership Hires
-
Defiance Launches ONDL: The First Daily 2X Long ETF for Ondas Holdings Inc.
-
The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)
-
Seyond Announces $2.6M Collaboration with Aventi Sweden to Enhance Market Presence
-
YETI Holdings, Inc. Announces Participation in the 28th Annual ICR Conference
-
Captivision Engages Firm to Validate Proven Mining Reserves Ahead of Planned Acquisition
-
Kratos Successfully Completes First Factory Acceptance Test of EPOCH® Command and Control System with Airbus’ Software-Defined Satellite
-
InnovAge Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference
-
Edible Garden Appoints Capital Markets Veteran Michael Naidrich to Board of Directors

